Successfully unsubscribed from ET Wealth

Dear vijayarajblogthis, As per your request, you have been removed from our mailing list for ET Wealth

Get all from the world of business delivered straight to your inbox Getting bigger and stronger. 4 million+ subscribers MANAGE ALL NEWSLETTERS» Daily Newsletter Your daily dose of business news, views and updates. SUBSCRIBE ET Economy Get the latest on economy, policy, insights & trends SUBSCRIBE Tech The latest buzz in tech sector, handpicked just for you SUBSCRIBE Markets Watch Latest stock market & business news SUBSCRIBE Wealth The week's best and important stories for all your personal finance SUBSCRIBE Prime Daily Prime stories of the day         SUBSCRIBE

About us|Advertise with us|Feedback|Sitemap|Code of Ethics © 2020 Times Internet Limited.

To ensure delivery directly to your inbox, please add etnotifications@indiatimes.com to your address book today. To unsubscribe or edit your subscriptions please click here

Successfully unsubscribed from Daily Newsletter

Dear vijayarajblogthis, As per your request, you have been removed from our mailing list for Daily Newsletter

Get all from the world of business delivered straight to your inbox Getting bigger and stronger. 4 million+ subscribers MANAGE ALL NEWSLETTERS» Daily Newsletter Your daily dose of business news, views and updates. SUBSCRIBE ET Economy Get the latest on economy, policy, insights & trends SUBSCRIBE Tech The latest buzz in tech sector, handpicked just for you SUBSCRIBE Markets Watch Latest stock market & business news SUBSCRIBE Wealth The week's best and important stories for all your personal finance SUBSCRIBE Prime Daily Prime stories of the day         SUBSCRIBE

About us|Advertise with us|Feedback|Sitemap|Code of Ethics © 2020 Times Internet Limited.

To ensure delivery directly to your inbox, please add etnotifications@indiatimes.com to your address book today. To unsubscribe or edit your subscriptions please click here

Financiación no bancaria

Líneas no bancarias para Pymes Préstamos de fondos de inversión Operaciones sin avales ni garantías a partir de 500.000 euros y hasta 15 millones. Periodos de amortización de hasta 7 años con un máximo de 4 de carencia. Crowdlending Préstamo en masa que no lleva asociados otros productos, no computa en Cirbe y no exige que se perpetúe la relación prestamista/prestatario. Pagarés corporativos Para empresas en crecimiento. Producto muy flexible que actúa como reserva de tesorería y permite regular desfases puntuales. Leaseback y Rentback Venta y posterior arrendamiento financiero de inmovilizado material. Condiciones (plazos y costes) muy favorables y ventajas fiscales. Renting y Leasing Líneas óptimas para la inversión en maquinaria. Aunque tanto el Renting como el Leasing se verán reflejados en el pasivo de la empresa, el Renting no computará en Cirbe. Factoring y otras líneas de descuento Adelanto de derechos de cobro (pagarés, facturas, recibos, contratos...) propiedad de la empresa para reducir las diferencias temporarias entre cobros y pagos y disponer de liquidez. Si quieres saber más, analizamos tu caso sin compromiso... Déjanos tus datos y te llamamos Si lo prefieres puedes llamarnos al 981 90 49 49 (de lunes a viernes de 9 a 16 horas)

Russian vaccine gets a shot in India

To keep you updated, we send Daily Newsletter to your mailbox. In case, you wish to Unsubscribe Click Here

Daily Newsletter Wed, Sep 16, 2020 | 05:51 PM IST

#ImpactOfTrumpVisaBan#AllAboutH-1BVisa#Coronavirus#EconomyTracker#Whatsbuzzing

Top stories of the day Dr Reddy's to make Sputnik V, the Russian Covid vaccine, for India Adding that the platform of human adenoviral vectors, which is the core of the Russian vaccine, has been tested in mo... Das is ready to do whatever it takes to save economy India's shadow banks are riding out the crisis China, India in eyeball-to-eyeball standoff India's GDP to contract by 8.6% in FY21, fiscal: UBS SBI could be sitting on $40 bn goldmine RBI staff can now switch from CPF to pension scheme Serum gets nod to resume Oxford vaccine trial

Prime special JioMart will be a disruptor. Will it allay livelihood concerns? JioMart and its competitors are likely to capture 3%-5% of the total FMCG and grocery market in a few years. That, in itself, will be a massive disruption. But JioMart will have to allay the concerns of thousands of general-trade distributors and not excessively encroach upon their livelihoods.

SENSEX 39302.85 258.50 NIFTY 50 11604.55 82.75 USD/INR 73.52 -0.14

Top Gainers NSE 2 companies (largecap) appreciated more than 5% TheRamcoCements 5.18% DLF 5.01% More from Gainers Top Losers NSE 2 companies (largecap) price decreased more than -3% Ksolves India Ltd. -4.98% SAIL -3.68% More from Losers

More From our Partners This brand is ensuring utmost patient safety and how Medicines, health supplements, medical devices, surgical equipment and diagnostic kits need specialised protection.

Question for India: Do we have enough freezers for a vaccine? One critical challenge will be storage and transportation. Some of the vaccines that use the new messenger RNA techno... At JPMorgan, productivity falls for WFH staff SFF raises stakes in India-China clash Isolated, China's tech giants seek home comfort TCS wants more women leaders in top deck ADP is shifting focus back on development ONGC exits Sudan due to non-payment of dues Testing may become must for int'l passengers Israel, UAE, Bahrain sign Abraham Accord

More From our Partners 7 Unique TV features that will blow your mind Beauty with Brilliance! A television like never before

Top Slideshow Army readies for winter to keep China in check Top Video Economy showing signs of stability: RBI

Follow Us on ET:

About us|Advertise with us|Feedback|Sitemap|Code of Ethics © 2020 Times Internet Limited.

To ensure delivery directly to your inbox, please add etnotifications@indiatimes.com to your address book today. If you are having trouble viewing this newsletter, please click here

To unsubscribe or edit your subscriptions please click here